MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Strongbridge Biopharma plc Company Profile (NASDAQ:SBBP)

Consensus Ratings for Strongbridge Biopharma plc (NASDAQ:SBBP) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.80 (239.78% upside)

Analysts' Ratings History for Strongbridge Biopharma plc (NASDAQ:SBBP)
Show:
DateFirmActionRatingPrice TargetActions
4/25/2016HC WainwrightInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Roth CapitalInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2015Janney Montgomery ScottInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015JMP SecuritiesInitiated CoverageOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha